The differing trends may be related to differences in pandemic severity and local political responses, but are also reflective of existing trends from before COVID-19; the opioid crisis that is prominent throughout the US has not affected Australia nor Europe to the same extent ). Trends we observed for pharmaceuticals are more similar to those reported by the Austrian study; though there is some variation individual compound results, both studies show consistent levels of long term medications such as betablockers and anticonvulsants and lowered levels of short term medications such as analgesics and pharmaceuticals .